STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more
The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 702 articles · page 18 of 20 · fetched about 1 hour ago
STAT+: Why benchmarking clinical LLMs from OpenEvidence, Doximity is complicated
In this edition of AI Prognosis: A conversation about benchmarking leading clinical chatbots, investor view on AI in…
Read at source →
Fauci invokes Fifth Amendment in declining to answer questions before Senate panel
At a highly anticipated Senate hearing, Anthony Fauci evoked his Fifth Amendment right to refuse to answer questions…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
A neglected issue in pedestrian, biker deaths
Fauci's testimony, visa time limits for research students, and more health news from Morning Rounds
Read at source →
STAT+: FDA expert panel recommends against approval of Capricor’s Duchenne drug
STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has…
Read at source →
STAT+: Clinical chatbots are taking medicine by storm. Should doctors trust them?
As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and…
Read at source →
STAT+: In the biotech industry, a most-wanted fugitive was long hiding in plain sight
Ronald Fischer, a most-wanted fugitive, was long hiding in the biotech industry in plain sight, and using an alias more…
Read at source →
Opinion: The VA could help America win the biotechnology race with China
“Together, HHS, the VA, and the DOD form a strong American innovation ecosystem — one that China and other competitors…
Read at source →
Opinion: Prolonged hospital stays can leave children isolated. It needs to change
“The effects of isolation extend far beyond children’s time in the hospital,” writes medical student Anna Tsioulias.
Read at source →
STAT+: American Diabetes Association, facing calls for resignations, asks for patience
An open letter to the board of the American Diabetes Association said the board had badly mishandled an incident at its…
Read at source →
Six key issues we’re watching at Fauci’s hearing
Sen. Rand Paul is forcing Fauci to appear before his Senate panel.
Read at source →
Visa time limits on foreign Ph.D. students and postdocs will harm U.S. science, experts warn
A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the…
Read at source →
STAT+: Bracing for another Fauci hearing
Plus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.
Read at source →
STAT+: GSK lays out plans to cut costs, pursue more late-stage drug trials
New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward…
Read at source →
STAT+: FDA staff reiterate concerns about Replimune skin cancer treatment
Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of…
Read at source →STAT+: Pharmalittle: We’re reading about FDA views on a Duchenne drug, GSK cost savings, and more
The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives —…
Read at source →
STAT+: Three questions with Whoop’s new CMO
In this edition of STAT Health Tech: A chat with Whoop's new chief medical officer, an update on CMS health tech…
Read at source →
Anthony Fauci’s pandemic-era diary entries
New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds
Read at source →
STAT+: Preliminary trial results suggest a path to a safer Alzheimer’s treatment
ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might…
Read at source →
STAT+: CMS evaluates one year of health tech progress, announces eight new pledge categories
One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump…
Read at source →
STAT+: From ‘lost cause’ to gold rush: Biotechs swarm to cure AATD
Biotech companies are racing to cure alpha-1 antitrypsin deficiency, AATD, fueling patent disputes, startup defections,…
Read at source →
Opinion: STAT+: Dementia finally has a business model
The big takeaway from the recent Alzheimer’s Association International Conference in London is an economic message:…
Read at source →
After PCOS became PMOS, there’s hope for new awareness among Black and Latina women
Growing awareness of a painful endocrine disorder now named PMOS is good news for women of color, who have high…
Read at source →
STAT+: HIV resurgence is feared as global funding to combat the disease falls 18%
The world risks a resurgence of the HIV epidemic after international financing to combat the disease suffered a…
Read at source →
STAT+: Pharma’s drug spending deflection
Job lock, surging prescription drug costs, No Surprises Act update, and more from STAT's Health Care Inc.
Read at source →
STAT+: Sarepta names Michael Severino, former Tessera CEO, as new chief executive
The beleaguered Sarepta Therapeutics named Michael Severino, who previously led Tessera Therapeutics, as its new CEO.
Read at source →STAT+: Pharmalittle: We’re reading about a U.S. peptide panel’s votes, Amgen scuffling with the FDA, and more
An FDA panel recommended that compounding pharmacies be allowed to make two more peptides, a step toward RFK Jr.'s goal…
Read at source →
STAT+: Ahead of hearing, FDA questions the efficacy of Capricor’s Duchenne drug
Ahead of a hearing, the FDA raised questions about the benefits of a Duchenne treatment from Capricor Therapeutics,…
Read at source →
A trend that isn’t fading, ultra-processed baby foods
An FDA advisory panel serves some peptide wins, a measles record, and more health news from Morning Rounds
Read at source →
STAT+: RA Capital backs upstart rival to Ultragenyx and Ionis in rare brain disease
Oak Hill Bio, a new company backed by RA Capital and other investors, will take on Ultragenyx and Ionis in developing…
Read at source →
Opinion: E-bikes, e-scooters are a burgeoning pediatric public health emergency
“Emergency departments across America report dramatic increases in serious injuries from e-bikes and e-scooters,” write…
Read at source →
STAT+: As some medical schools embrace RFK Jr.’s nutrition push, they deftly sidestep MAHA priorities
Even as some medical schools heed health secretary Robert F. Kennedy Jr.’s call for more nutrition education, several…
Read at source →
Opinion: How midwives like me can help fight medical misinformation
“I have come to believe that changing a mind is rarely the point. Planting a seed is,” writes nurse-midwife Mara Evans.
Read at source →
STAT+: Argenx to buy Forte Biosciences for $2.2B
Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple…
Read at source →
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
“Consumers should not be faced with a trade-off between nutrition and food safety,” writes Susan Mayne, former director…
Read at source →
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
Robert F. Kennedy Jr. has lauded peptides and said he takes them himself.
Read at source →